Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
01 Octubre 2007 - 6:45AM
PR Newswire (US)
Delsym is the only FDA-approved 12-hour non-prescription liquid
cough suppressant CHESTER, N.J., Oct. 1 /PRNewswire-FirstCall/ --
Adams Respiratory Therapeutics, Inc. (NASDAQ:ARxT) today announced
that the Food and Drug Administration (FDA) approved its
supplemental New Drug Application for a grape-flavored formulation
of Delsym Extended-Release Suspension on Friday, Sept. 28, 2007.
The Company will immediately commence distribution of grape Delsym
product to its trade customers. Delsym is the first and only
over-the-counter (OTC) liquid that controls cough for a full 12
hours with a single dose, providing all day or all night cough
suppression with each dose. Delsym's patented single-ingredient
formula delivers great tasting medicine in orange and now new grape
flavors for both children and adults. About Adams Respiratory
Therapeutics, Inc. Adams is a specialty pharmaceutical company
focused on the late-stage development, commercialization and
marketing of over-the-counter and prescription pharmaceuticals for
the treatment of respiratory disorders. DATASOURCE: Adams
Respiratory Therapeutics, Inc. CONTACT: Janet M. Barth, Adams
Respiratory Therapeutics, Inc., +1-908-879-2428 Web site:
http://www.adamsrt.com/
Copyright